Human Phenotype Ontology

About
MSeqDR-LSDB
Tools
- Quick-Mitome for WES
- Quick-Mitome
- Quick-Mitome Report
- mtDNA Tool:
- mvTool
- Phy-Mer
- MToolBox
- mvTool for Haplogroup
- mvTool with HmtDB
- MitoMaster
- MitoTIP tRNA Scoring
- MSeq-OpenCGA
- Variant Tool:
- VariantOneStop
- HBCR Exome (Retired)
- POLG Patho. Server
- Data - Awsomics GeEx
- Expert Panel
- Panel Tool:
- Gene Panel Examiner
- Transgenomic_NuclearMitome
- Pedigree Maker
- json2table
Phenome-Disease
Collaboration
- Genesis (GEM.App)
- LeighMap
- Expert Panel
- Collaboration Zone
Submission
- Submit_Interpret_Variant
- Instructions

Hello! Guest! Please Login or Register! Clinician Mode

Examples Gene: MT-ND1, POLG, Region: M:1-1000 Variant: m.8993T>G, 1:g.10042757T>C rs3888511 MSCV_0000006, ClinVar: RCV000000015, Disease: Leigh syndrome, Phenotype: Retinopathy

Grandparent Node:
Abnormal circulating protein concentration (HP:0010876)

Parent Node:
Abnormal circulating beta globulin level (HP:0025465)

..Starting node
..Abnormality of circulating beta-2-microglobulin level (HP:0025345)

Term ID:

25345

Name:

Abnormality of circulating beta-2-microglobulin level

Synonym:

Abnormality of circulating B2M level; Abnormality of circulating beta2 microglobulin level; Abnormality of circulating beta2-m level; Abnormality of circulating beta2m level

Definition:

A deviation from the normal concentration of beta-2-microglobulin in the blood.

Comments:

Reference:

HP:0025345

Genes and Diseases:

Child Nodes:

........

Increased circulating beta-2-microglobulin level (HP:0025346)

........

Decreased circulating beta-2-microglobulin level (HP:0025347)

Sister Nodes:

Abnormal angiostatin level (HP:0031439)

Abnormal circulating properdin level (HP:0031300)

Abnormal sex hormone-binding globulin level (HP:0031438)

Atransferrinemia (HP:0012239)

Decreased level of plasminogen (HP:0040228)

Input	HPO ID	HPO term	Distance	Gene	Gene id entrez	HGNC ID	DiseaseId	DiseaseName	Frequency	ClinVar variants
HPO disease - gene - phenotype typical associations:
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0025345	HP:0025345	Abnormality of circulating beta-2-microglobulin level	0	B2M CL E G H	567	914	OMIM:241600	Immunodeficiency 43		8
HP:0025345	HP:0025345	Abnormality of circulating beta-2-microglobulin level	0	CIITA CL E G H	4261	7067	ORPHA:572	Immunodeficiency by defective expression of MHC class II		118
HP:0025345	HP:0025345	Abnormality of circulating beta-2-microglobulin level	0	RFX5 CL E G H	5993	9986	ORPHA:572	Immunodeficiency by defective expression of MHC class II		38
HP:0025345	HP:0025345	Abnormality of circulating beta-2-microglobulin level	0	RFXANK CL E G H	8625	9987	ORPHA:572	Immunodeficiency by defective expression of MHC class II		26
HP:0025345	HP:0025345	Abnormality of circulating beta-2-microglobulin level	0	RFXAP CL E G H	5994	9988	ORPHA:572	Immunodeficiency by defective expression of MHC class II		34
HP:0025345	HP:0025346	Increased circulating beta-2-microglobulin level	1	CL E G H
HP:0025345	HP:0025347	Decreased circulating beta-2-microglobulin level	1	B2M CL E G H	567	914	OMIM:241600	Immunodeficiency 43		8
HP:0025345	HP:0025347	Decreased circulating beta-2-microglobulin level	1	CIITA CL E G H	4261	7067	ORPHA:572	Immunodeficiency by defective expression of MHC class II	HP:0040282 - Frequent	118
HP:0025345	HP:0025347	Decreased circulating beta-2-microglobulin level	1	RFX5 CL E G H	5993	9986	ORPHA:572	Immunodeficiency by defective expression of MHC class II	HP:0040282 - Frequent	38
HP:0025345	HP:0025347	Decreased circulating beta-2-microglobulin level	1	RFXANK CL E G H	8625	9987	ORPHA:572	Immunodeficiency by defective expression of MHC class II	HP:0040282 - Frequent	26
HP:0025345	HP:0025347	Decreased circulating beta-2-microglobulin level	1	RFXAP CL E G H	5994	9988	ORPHA:572	Immunodeficiency by defective expression of MHC class II	HP:0040282 - Frequent	34

Genes (5) :B2M CIITA RFX5 RFXANK RFXAP

Diseases (2) :OMIM:241600 ORPHA:572

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.

Feedback about the webpages , or email to MSeqDR webmaster: Lishuang Shen